Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo

M. Zhao, James Pipe, J. Bonnett, J. L. Evelhoch

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

Nuclear magnetic resonance (NMR) non-invasively measures the apparent diffusion coefficient (ADC) of water, which is sensitive to the biophysical characteristics of tissue. Because anti-cancer treatment alters tumour pathophysiology, tumour ADC may be altered by treatment. In order to test this hypothesis, ADC was measured in s.c. implanted murine RIF-1 tumours before and up to 9 days after treatment with cyclophosphamide. A dose-dependent, reversible increase in tumour ADC was observed after cyclophosphamide treatment, which is consistent with an increase in the fraction of interstitial water due to treatment-induced cell death. Because tumour water ADC is increased substantially at a time when there is no change in tumour volume for a dose which produces minimal cell kill, its measurement could provide a novel means for early detection of response to anti-cancer therapy. If the changes in ADC observed in the present study are evident for commonly used anti-cancer therapies in different tumour types and specific to a therapeutic response, this approach could be broadly applicable as a response predictor since magnetic resonance imaging can be used to measure ADC in human tumours.

Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalBritish Journal of Cancer
Volume73
Issue number1
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Magnetic Resonance Spectroscopy
Neoplasms
Cyclophosphamide
Water
Tumor Burden
Cell Death
Therapeutics
Magnetic Resonance Imaging

Keywords

  • Nuclear magnetic resonance
  • RIF-1
  • Therapeutic response
  • Tumour pathophysiology
  • Tumour water

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. / Zhao, M.; Pipe, James; Bonnett, J.; Evelhoch, J. L.

In: British Journal of Cancer, Vol. 73, No. 1, 01.01.1996, p. 61-64.

Research output: Contribution to journalArticle

@article{40bdc70ee48447939be5de8452558de5,
title = "Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo",
abstract = "Nuclear magnetic resonance (NMR) non-invasively measures the apparent diffusion coefficient (ADC) of water, which is sensitive to the biophysical characteristics of tissue. Because anti-cancer treatment alters tumour pathophysiology, tumour ADC may be altered by treatment. In order to test this hypothesis, ADC was measured in s.c. implanted murine RIF-1 tumours before and up to 9 days after treatment with cyclophosphamide. A dose-dependent, reversible increase in tumour ADC was observed after cyclophosphamide treatment, which is consistent with an increase in the fraction of interstitial water due to treatment-induced cell death. Because tumour water ADC is increased substantially at a time when there is no change in tumour volume for a dose which produces minimal cell kill, its measurement could provide a novel means for early detection of response to anti-cancer therapy. If the changes in ADC observed in the present study are evident for commonly used anti-cancer therapies in different tumour types and specific to a therapeutic response, this approach could be broadly applicable as a response predictor since magnetic resonance imaging can be used to measure ADC in human tumours.",
keywords = "Nuclear magnetic resonance, RIF-1, Therapeutic response, Tumour pathophysiology, Tumour water",
author = "M. Zhao and James Pipe and J. Bonnett and Evelhoch, {J. L.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1038/bjc.1996.11",
language = "English (US)",
volume = "73",
pages = "61--64",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo

AU - Zhao, M.

AU - Pipe, James

AU - Bonnett, J.

AU - Evelhoch, J. L.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Nuclear magnetic resonance (NMR) non-invasively measures the apparent diffusion coefficient (ADC) of water, which is sensitive to the biophysical characteristics of tissue. Because anti-cancer treatment alters tumour pathophysiology, tumour ADC may be altered by treatment. In order to test this hypothesis, ADC was measured in s.c. implanted murine RIF-1 tumours before and up to 9 days after treatment with cyclophosphamide. A dose-dependent, reversible increase in tumour ADC was observed after cyclophosphamide treatment, which is consistent with an increase in the fraction of interstitial water due to treatment-induced cell death. Because tumour water ADC is increased substantially at a time when there is no change in tumour volume for a dose which produces minimal cell kill, its measurement could provide a novel means for early detection of response to anti-cancer therapy. If the changes in ADC observed in the present study are evident for commonly used anti-cancer therapies in different tumour types and specific to a therapeutic response, this approach could be broadly applicable as a response predictor since magnetic resonance imaging can be used to measure ADC in human tumours.

AB - Nuclear magnetic resonance (NMR) non-invasively measures the apparent diffusion coefficient (ADC) of water, which is sensitive to the biophysical characteristics of tissue. Because anti-cancer treatment alters tumour pathophysiology, tumour ADC may be altered by treatment. In order to test this hypothesis, ADC was measured in s.c. implanted murine RIF-1 tumours before and up to 9 days after treatment with cyclophosphamide. A dose-dependent, reversible increase in tumour ADC was observed after cyclophosphamide treatment, which is consistent with an increase in the fraction of interstitial water due to treatment-induced cell death. Because tumour water ADC is increased substantially at a time when there is no change in tumour volume for a dose which produces minimal cell kill, its measurement could provide a novel means for early detection of response to anti-cancer therapy. If the changes in ADC observed in the present study are evident for commonly used anti-cancer therapies in different tumour types and specific to a therapeutic response, this approach could be broadly applicable as a response predictor since magnetic resonance imaging can be used to measure ADC in human tumours.

KW - Nuclear magnetic resonance

KW - RIF-1

KW - Therapeutic response

KW - Tumour pathophysiology

KW - Tumour water

UR - http://www.scopus.com/inward/record.url?scp=0030047282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030047282&partnerID=8YFLogxK

U2 - 10.1038/bjc.1996.11

DO - 10.1038/bjc.1996.11

M3 - Article

VL - 73

SP - 61

EP - 64

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -